{"filings":[{"id":748680,"accession_number":"0001493152-26-026414","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2026-05-29T21:00:24+00:00","items":["5.02"],"status":"ready","headline":"Scienture CFO Eric Sherb resigns; co-CEO Narasimhan Mani named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Sherb resigned as CFO effective May 26, 2026; cited personal reasons, no disagreement with management or board.","Dr. Narasimhan Mani appointed Interim CFO same day; Mani also serves as co-CEO, President, and director.","Mani holds an MBA in Finance from Columbia Business School and has 25+ years in pharma leadership roles.","No material transaction or family relationship between Mani and the company; employment governed by existing agreement.","Mani previously served as CEO of Kesin Pharma and Xiromed, and VP strategy at Amneal Pharmaceuticals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":611516,"accession_number":"0001493152-26-025062","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2026-05-22T21:00:37+00:00","items":["2.02","9.01"],"status":"ready","headline":"SCIENTURE Q1 revenue $56k (+449% YoY); gross margin 95.6%; net loss $3.4M; secures $11M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $56k (+449% YoY); gross profit $54k (+7,900%); gross margin 95.6% vs 6.6%.","Net loss $3.4M vs $3.1M; operating expenses flat at ~$3.56M.","USPTO granted third patent for Arbli (losartan) extending exclusivity through 2041; REZENOPY got Orange Book patent.","GPO agreements for REZENOPY covering 5,000+ institutions; sales force starts June 1, 2026.","Secured $11M non-dilutive debt financing to support commercialization and R&D pipeline."],"consensus_eps_estimate":-0.2244,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":56325.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92531,"accession_number":"0001493152-26-021327","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Scienture Holdings posts revised investor presentation; no specific details provided in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filed an 8-K announcing a revised investor presentation posted on its website.","Presentation intended for use in meetings with analysts and potential investors.","Filing contains no financial results or operational updates; exhibit content not included in input.","Company disclaims any obligation to update the presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92530,"accession_number":"0001493152-26-020931","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Scienture Holdings secures $11M secured note financing from Streeterville Capital","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$8.42M A-1 Note (net $8M after $400K OID) and $3M B Note issued; total proceeds $11M.","A-1 Note bears 9% interest, 18-month maturity; B Note bears 5% interest, 18-month maturity, funds held in DACA.","B Note may be exchanged for additional A Notes in $1M increments as A-1 balance reduces.","After 8 months, Lender can redeem up to $175k/month or 10% daily volume if stock >20% above min price.","Proceeds for working capital, commercialization, product development, and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119682,"accession_number":"0001493152-25-023944","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Scienture Holdings posts revised investor presentation; no material new details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Revised investor presentation posted on www.scientureholdings.com for use at analyst and investor meetings.","Presentation is dated November 17, 2025 and contains forward-looking statements without specific financial updates.","No earnings, M&A, leadership changes, or other material events were disclosed in the 8-K or accompanying exhibit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119681,"accession_number":"0001493152-25-023614","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Scienture shareholders reject 20x authorized share increase; approve reverse split and equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proposal to boost authorized common shares from 100M to 2B and preferred from 10M to 200M was rejected (5.3M for, 5.5M against).","Approved amendment to 2019 Plan increasing pool from 5M to 25M shares (5.6M for, 5.2M against).","Approved potential future offering >20% of outstanding at below minimum price under Nasdaq Rule 5635(d) (5.6M for, 5.2M against).","Board granted discretion to effect reverse stock split between 1:2 and 1:50 (6.3M for, 4.7M against).","All five director nominees elected with >9.4M votes each; no broker non-votes for Proposal 5."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119680,"accession_number":"0001493152-25-022385","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Scienture increases at-the-market equity facility to $150M via Maxim Group","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Maximum aggregate offering price under ATM agreement raised to $150 million; entire amount remains available as of Nov 7, 2025.","Equity distribution agreement with Maxim Group LLC dated September 19, 2025 governs sales of common stock.","Prospectus supplement filed November 7, 2025 amends Form S-3 registration statement (No. 333-289198).","Company may sell shares from time to time at prevailing market prices; no specified use of proceeds or minimum price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119679,"accession_number":"0001493152-25-020261","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Scienture Holdings increases ATM offering capacity by $9.6M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed prospectus supplement to sell up to $9,592,009 in common stock under ATM facility.","Already sold $13,252,250 in gross proceeds under the same program in prior 12 months.","Equity distribution agreement with Maxim Group LLC dated September 19, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119678,"accession_number":"0001493152-25-019341","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Scienture Holdings amends co-CEO employment agreements, increases base salaries and severance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Mani's base salary raised from $325,000 to $400,000; Dr. Hariharan's from $175,000 to $400,000.","Severance benefit increased to 24 months base salary in non-CIC termination, 2x sum in CIC termination.","COBRA and insurance benefits extended from 12 to 24 months post-termination.","Amendments effective October 1, 2025, approved by Compensation Committee.","Formalized Dr. Mani as President/Co-CEO and Dr. Hariharan as Executive Chairman/Co-CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119677,"accession_number":"0001493152-25-018505","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Scienture receives Nasdaq delisting notice for bid price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice received Oct 14, 2025 for non-compliance with Nasdaq Listing Rule 5450(a)(1).","Common stock bid price below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until April 13, 2026, to regain compliance.","To cure, minimum bid must close at $1.00+ for 10 consecutive business days.","Company believes it can regain compliance but provides no assurance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119676,"accession_number":"0001493152-25-018332","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["1.01","2.03","1.02","9.01"],"status":"ready","headline":"Scienture refinances $2.7M NVK loan with $3.9M Streeterville note, issues 250K shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered $3,911,111 senior secured note (net $3.5M) with Streeterville Capital; 9% interest, 7-month term.","Used net proceeds to fully repay NVK Loan balance of $2,656,250 as of Oct 15, 2025.","Issued 250,000 common shares to NVK as consideration for loan extension to Dec 8, 2025.","NVK waived existing events of default; company paid $25K amendment fee plus $25K maturity fee.","New note secured by all company assets and guaranteed by subsidiary Scienture, LLC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119675,"accession_number":"0001493152-25-017117","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Scienture Holdings reduces stockholder quorum requirement to one-third","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board voted Oct 1, 2025 to amend Bylaws, lowering quorum from majority to one-third of voting stock.","Amendment to Section 2.8 applies to all stockholder meetings going forward.","Change intended to facilitate meeting conduct; no other bylaw provisions altered.","Company’s common stock trades on Nasdaq under symbol SCNX."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":119674,"accession_number":"0001493152-25-016882","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Scienture Holdings converts $559K debentures to equity at $2.4861/share, terminates Arena debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Conversion price of 10% OID secured debentures amended to $2.4861 per share.","Arena Finance Markets converts $454,647.03; Arena Special Opportunities III converts $104,718.89 into common stock.","Upon full conversion, all debentures, liens, and transaction documents terminated and released.","Obligations paid in full except certain registration and purchase agreement obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136250,"accession_number":"0001493152-25-014658","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Scienture Holdings enters $9.2M ATM equity distribution agreement with Maxim Group","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total gross sales price up to $9.2M under shelf registration (Form S-3).","Maxim Group will receive 3% commission on shares sold; company reimburses certain expenses.","Sales may occur from time to time via Nasdaq or other methods; no minimum obligation.","Agreement terminates upon $9.2M sold or earlier by notice from either party.","Legal opinion of Dykema Gossett PLLC on legality of share issuance filed as Exhibit 5.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136249,"accession_number":"0001641172-25-024477","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Scienture raises ~$3.9M via registered direct offering of 3.225M shares at $1.20/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 3,225,000 shares at $1.20/share for gross proceeds of ~$3.9M; closed August 15, 2025.","Maxim Group LLC is sole placement agent; receives 7% cash fee and up to $50,000 expense reimbursement.","Officers and directors entered 90-day lock-up agreements restricting share sales post-offering.","Company also sold 1,110,060 shares for ~$1.76M under prior Common Stock Purchase Agreements (now terminated).","Proceeds used for working capital, capex, product development, and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136248,"accession_number":"0001641172-25-020877","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Scienture raises up to $3M in bridge funding; secures $1.2M initially","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved capital raise of up to $3M; Company sold 754,716 shares at $1.59 per share.","Received approx $1.2M from investors including BlueCap Ventures, Jinal Sheth, Nimish Sheth, Chintan Shah.","No warrants, options, or convertible securities issued; only common stock.","Proceeds to support upcoming commercial launches and pipeline development.","Additional proceeds up to $3M may be raised in the future."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":136247,"accession_number":"0001641172-25-017841","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-07-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Scienture Holdings enters indemnification agreements with five directors/officers","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Agreements with Mayur Doshi, Donald Fell, Shankar Hariharan, Subbarao Jayanthi, and Narasimhan Mani.","Provides indemnification and expense advancement to maximum extent permitted by Delaware law.","Rights are in addition to those under charter, bylaws, and applicable law."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153327,"accession_number":"0001641172-25-011945","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["1.02","1.01","3.01","5.02","9.01"],"status":"ready","headline":"Scienture Holdings CEO and President resign; Nasdaq bid-price deficiency received","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Suren Ajjarapu and Chairman resigned May 16; President Prashant Patel resigned May 20, both no disputes.","Dr. Narasimhan Mani and Dr. Shankar Hariharan appointed co-CEOs effective May 20; Mani also President and director.","Terminated purchase agreement with Arena Business Solutions Global SPC II effective May 22, no penalties.","Nasdaq notice May 19: bid price below $1 for 30 days; 180 days until Nov 17, 2025 to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":153326,"accession_number":"0001641172-25-003812","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Scienture divests IPS and Bonum to Tollo for $5M note; focuses on Specialty Pharma","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total consideration is $5M in a promissory note bearing interest at prime rate, maturing June 30, 2030.","Closing expected June 30, 2025; Tollo must pay 20% of future equity proceeds toward the note.","CEO Suren Ajjarapu and President Prashant Patel have beneficial interest in buyer Tollo (related party).","Proceeds will fund high-growth product development at Scienture, LLC subsidiary.","Divestiture includes legacy Healthcare IT (IPS, Bonum, Softell) to streamline operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172116,"accession_number":"0001493152-25-011152","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Scienture receives FDA approval for Arbli (losartan oral suspension); launch planned Q3 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA approves SCN-102 as Arbli (losartan potassium oral suspension), first liquid ready-to-use losartan in US.","Arbli indicated for hypertension (age >6), stroke risk reduction, diabetic nephropathy.","US losartan market $292M annual sales, 68M prescriptions (IQVIA Dec 2024); global $1.5B.","Commercial launch expected Q3 2025; product has 18-month shelf life at room temp.","Consulting agreement with Draper Inc. for IR/business dev: 100k shares initial + 100k/mo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172115,"accession_number":"0001493152-25-010215","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["1.01","5.02","5.07","9.01"],"status":"ready","headline":"Scienture appoints Eric Sherb as CFO; Patel steps down as interim principal financial officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Sherb appointed CFO effective March 13, 2025; he served as accounting consultant since 2023.","Sherb receives annual cash fee of $100,000, $50,000 in stock, and discretionary bonus.","Prashant Patel resigns as interim principal financial/accounting officer but remains President/COO.","Shareholders elected all five director nominees and ratified CM3 Advisory as auditor for FY2025.","Say-on-pay approved on advisory basis; 1-year frequency selected for future advisory votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172114,"accession_number":"0001493152-25-009737","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Scienture gets exclusive US rights to commercialize REZENOPY naloxone nasal spray from Kindeva","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive 10-year US license to commercialize REZENOPY (naloxone HCl 10mg) from Kindeva; term expires 10 yrs from first commercial sale.","Supply price $9.20/unit; profit-sharing 10% of net sales (8% upon generic entry); additional 5% until $12.8M NDA cost recovered.","Milestone payments up to $10M based on net sales targets; $1M upfront milestones due in stages.","Minimum order: 3 batches of 450,000 units/year from 2027 or $1.242M/year; $189M total naloxone market (IQVIA MAT Dec 2024)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172113,"accession_number":"0001493152-25-002749","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-01-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Two directors resign from Scienture Holdings; board reduced to 5 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Narasimhan Mani resigned as director on Jan 15, 2025; Prashant Patel resigned on Jan 16, 2025.","Both resignations were voluntary and not due to any dispute or disagreement with the company.","They will not receive compensation for 2025 board service but will remain in management roles.","Board size reduced from 7 to 5 directors; currently no vacancies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172112,"accession_number":"0001493152-25-001429","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2025-01-08T23:59:59+00:00","items":["3.01","7.01","8.01","9.01"],"status":"ready","headline":"Scienture receives Nasdaq delisting notice for missing 2024 annual meeting; corrects prior 8-K","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Jan 3, 2025 for non-compliance with Listing Rule 5620(a) due to no 2024 annual meeting.","Has until Feb 18, 2025 to submit a plan; Nasdaq may grant until June 30, 2025 to regain compliance.","Company intends to hold annual meeting as soon as practicable to regain compliance.","Corrected prior 8-K: Superlatus Holding Supplier Agreement was unauthorized; former subsidiary reps likely acted unilaterally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189087,"accession_number":"0001493152-24-047804","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Scienture secures $3M first tranche of convertible debentures and $50M ELOC","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["First closing on Nov 25, 2024: $3,333,333 principal of 10% OID secured convertible debentures issued for $3,000,000.","Up to $12,222,222 total principal in three tranches; conversion price at 92.5% of lowest 5-day VWAP.","Entered $50M equity line of credit with Arena Business Solutions, 36-month term, 96% of VWAP pricing.","Issued 55,000 commitment shares at first closing; additional shares due for future tranches and ELOC.","Dawson James acted as sole placement agent; 7% fee on gross proceeds, expenses up to $100,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189086,"accession_number":"0001493152-24-040822","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-10-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Scienture Holdings converts all Series X Preferred Stock into 6.8M common shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["6,826,713 common shares issued upon conversion of all outstanding Series X Preferred Stock on Sep 20, 2024.","Post-conversion common shares outstanding total 8,576,795.","Conversion simplifies capital structure; no other material events reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189085,"accession_number":"0001493152-24-040392","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-10-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Scienture Holdings files investor presentation; no material new facts disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor presentation dated October 4, 2024, furnished as Exhibit 99.1.","Presentation intended for meetings with analysts and investors; content not detailed in filing.","No earnings, M&A, or other material events disclosed in the 8-K text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205568,"accession_number":"0001493152-24-037953","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-09-24T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"TRxADE Health renamed Scienture Holdings; ticker changes to SCNX on Nasdaq","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change effective September 23, 2024; new CUSIP 80880X104.","Stock now trades on Nasdaq under ticker SCNX; old ticker MEDS discontinued.","Prior all-stock business combination with Scienture LLC valued at $103 million.","Executive team and board unchanged; Suren Ajjarapu remains CEO and Chairman.","Subsidiaries include Scienture LLC (specialty pharma) and Integra Pharma Solutions (wholesale)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205570,"accession_number":"0001493152-24-029787","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["1.01","5.03","2.01","3.02","3.03","5.02","7.01","9.01"],"status":"ready","headline":"TRxADE HEALTH completes merger with Scienture; issues Series X preferred convertible to common","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed merger with Scienture Inc. on July 25; Scienture holders get 291,555 common shares (19.99% of pre-deal float) and 6,826,713 Series X non-voting convertible preferred shares.","Company to rename to Scienture Holdings, Inc. after stockholder written consent becomes effective (20 days after information statement mailed).","Board expands to 7; Shankar Hariharan and Narasimhan Mani appointed as directors.","CEO and CFO remain; lock-up agreements prohibit transfer of shares for 180 days post preferred stock conversion.","Consulting agreements with Suren Ajjarapu (702,086 common shares) and Prashant Patel (614,325 common shares) effective upon termination of employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":205569,"accession_number":"0001493152-24-026571","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-07-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"TRxADE Health declares special $1.50/share dividend from asset sale proceeds","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Special cash dividend of $1.50 per share of common stock declared by board.","Record date July 19, 2024; payment on or about July 24, 2024.","Dividend funded with a portion of proceeds from May 2024 sale of web-based market platform assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222510,"accession_number":"0001493152-24-024424","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"TRxADE Health appoints Subbarao Jayanthi to board, Narasimhan Mani resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Subbarao Jayanthi appointed to TRxADE Health board on June 17, 2024.","Jayanthi is Managing Partner of RxC International, a biopharma strategy consulting firm.","Narasimhan Mani voluntarily resigned as director on June 17, 2024, with no dispute.","Jayanthi will receive equity and cash compensation per company independent director policies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222509,"accession_number":"0001493152-24-021967","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["3.01","5.02","7.01","9.01"],"status":"ready","headline":"TRxADE Health receives Nasdaq non-compliance notice for late Q1 10-Q; directors resign, new ones appointed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on May 23, 2024 for failing to timely file Q1 10-Q; must submit compliance plan by July 22, 2024.","Potential extension to Nov 18, 2024; no immediate effect on listing or trading.","Appointed Mayur Doshi (CEO of AlfaGene Bioscience) and Narasimhan Mani (former CEO of Kesin Pharma) as directors on May 28, 2024.","Directors Jeff Newell and Michael Peterson voluntarily resigned on May 30, 2024; no dispute with the Company.","Resigned directors receive cash compensation through June 30, 2024; unvested shares fully vested on resignation date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":222508,"accession_number":"0001493152-24-021170","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"TRxADE Health still unable to file Q1 10-Q, faces potential Nasdaq compliance issue","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Filed Form 12b-25 on May 15, but still unable to file Q1 10-Q for period ended March 31, 2024.","Non-compliance with Nasdaq Listing Rule 5250(c)(1) for timely periodic financial reports.","Believes stockholders' equity exceeds $2.5M as of March 31, 2024 due to proceeds from asset sale of Trxade, Inc.","Company remains under Panel Monitor for equity compliance through August 30, 2024.","No assurances on timing for filing Form 10-Q; working diligently to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242034,"accession_number":"0001493152-24-008947","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["8.01","1.01","2.01","9.01"],"status":"ready","headline":"TRxADE Health declares $8 special dividend from asset sale proceeds","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Special cash dividend of $8.00 per share declared; payable March 22, 2024 to holders of record March 18, 2024.","Dividend funded by proceeds from sale of web-based market platform assets (previously announced).","Company sold subsidiary Superlatus Inc. for $1 to Superlatus Foods Inc. on March 5, 2024.","Trxade subsidiary agreed to invest up to $5M in Lafayette Energy for convertible preferred stock; second tranche contingent on drilling success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242033,"accession_number":"0001493152-24-007038","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"TRxADE Health sells Trxade marketplace assets to Micro Merchant Systems for $22.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $22.5M cash at closing; additional $7.5M earnout if MMS collects ≥$1.6M from third parties within 4 months.","Closing occurred on February 16, 2024, same day as signing.","Seller retains Integra Pharma Solutions wholesaler business and other assets not tied to the web-based market platform.","TRxADE Health acts as guarantor for certain Trxade, Inc. obligations under the agreement.","Buyer Micro Merchant Systems, Inc. acquires substantially all assets of Trxade, Inc.'s pharmaceutical marketplace."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242032,"accession_number":"0001493152-24-002571","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-01-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"TRxADE Health files late Q3 2023 10-Q, says regains Nasdaq compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Filed Form 10-Q for period ended Sep 30, 2023, which was overdue since Nov 2023.","Company previously received Nasdaq noncompliance notice for late filing under Rule 5250(c)(1).","Believes it has now regained compliance with Nasdaq listing requirements.","This removes immediate risk of delisting due to filing delinquency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":242031,"accession_number":"0001493152-24-002099","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2024-01-11T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"TRxADE Health amends merger agreement with Superlatus; reduces consideration due to failed post-closing condition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Superlatus failed to meet post-closing condition to acquire Prestige Farms, leading to material breach.","Amendment reduces merger consideration from 30,821,941 common shares to 1,712,328 common shares at $7.30/share.","Superlatus surrenders 289,731 shares of Series B preferred stock back to the Company.","Company releases Superlatus from breach claims; agrees to assist with future acquisitions within 3 months.","Company Equity Value adjusted to $12,500,000 from previously higher value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259427,"accession_number":"0001493152-23-042872","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"TRxADE HEALTH receives Nasdaq delinquency notice for late 10-Q filing","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Nov 21, 2023 for non-compliance with Listing Rule 5250(c)(1).","Must submit plan to regain compliance by January 22, 2024.","Nasdaq may grant extension until May 20, 2024 to file the Q3 2023 10-Q.","Company filed Form 12b-25 on Nov 15, 2023, citing need for additional time.","No immediate delisting effect but risk increases with further delay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259426,"accession_number":"0001493152-23-042180","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-11-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"TRxADE HEALTH delays Q3 10-Q filing; expects Nasdaq non-compliance notice","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Company will not file Q3 2023 10-Q within the five-day grace period under Rule 12b-25.","Unable to complete financial statements without unreasonable effort; auditors unable to finish review.","Expects to file the delayed Form 10-Q by December 15, 2023.","Anticipates a Nasdaq non-compliance notice but expects to cure within the applicable grace period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259425,"accession_number":"0001493152-23-037138","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-10-13T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"TRxADE subsidiary Superlatus enters distribution partnership with Rainforest to reach 5,000+ retail locations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Superlatus appoints Rainforest as exclusive distributor in North Atlantic, Northeast, Midwest, Mid-Atlantic regions for CPG brands like Coolhaus and Spero.","Rainforest serves over 3,000 retailers across 15 states; partnership unlocks over 5,000 retail locations including Whole Foods, Kroger, ShopRite.","Rainforest has 50+ sales representatives; targets Tri-State area home to >33% of U.S. consumers via Direct Store Delivery.","Superlatus CEO Tim Alford says partnership provides substantial expansion opportunities; TRxADE plans to focus on Superlatus foods business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259424,"accession_number":"0001493152-23-036917","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-10-11T23:59:59+00:00","items":["3.02","5.03","9.01"],"status":"ready","headline":"TRxADE HEALTH raises $290k via private placement of Series C Preferred and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $290,000 from sale of 290 shares of Series C Convertible Preferred at $1,000/share to Hudson Global Ventures.","Issued warrant to purchase 41,193 shares at $7.20/share, exercisable for 5 years; also issued 40,000 commitment shares.","Series C Preferred convertible at lower of 85% of average lowest VWAPs; conversion price may drop to $5.00 or 25% of lowest traded price upon Triggering Event.","Company may redeem Series C at 115%-125% premium within 180 days; holders can force redemption at 135% upon Triggering Event.","Registration statement required within 15 days; negative covenants restrict share repurchases and affiliate deals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":259423,"accession_number":"0001493152-23-035327","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-10-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"TRxADE HEALTH subsidiary Superlatus acquires Spero Foods assets for cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Superlatus (wholly owned by TRxADE HEALTH) acquired all assets of Spero Foods on Oct 2, 2023, for cash.","Spero holds 21 global patents for plant-based dairy and egg alternatives using low-cost sustainable ingredients.","Spero brands join Superlatus's Urgent Company umbrella alongside Coolhaus, Modern Kitchen, and Brave Robot.","Spero plans 2024 launches of plant-based Mozzarella Sticks, Shreds, Cheddar Shreds, and reformulated cream cheese."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276707,"accession_number":"0001493152-23-032673","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"TRxADE Health dismisses MaloneBailey as auditor, engages CM3 Advisory","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed MaloneBailey, LLP as independent auditor effective Sept 14, 2023; audit committee approved.","Engaged CM3 Advisory as new independent registered public accounting firm.","No reportable events or disagreements in the two most recent fiscal years or subsequent interim period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276706,"accession_number":"0001493152-23-030131","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-08-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Superlatus (TRxADE subsidiary) to launch pulse-based protein snacks under Brave Robot in early 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dr. Gino Bortone, inventor of Twisted Cheetos, named CTO of Superlatus.","New pulse-based twisted protein snacks: 112 cal, 8g protein, 300% more protein than traditional snacks.","Price under $2 per bag; already sold in 300 Federated Co-Operatives in Canada under private labels.","Company targets US school snack market with better-for-you positioning and early 2024 launch."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276705,"accession_number":"0001493152-23-030055","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-08-24T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"TRxADE HEALTH subsidiary buys four consumer brand trademarks for $1.25M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Superlatus (TRxADE subsidiary) acquires trademarks for Coolhaus, Brave Robot, Modern Kitchen, California Performance Co. from Perfect Day and The Urgent Company for $1,250,000.","Closing expected within 7 days of August 21, 2023; no material liabilities assumed.","Also plans separate agreement by Aug 31 to purchase other assets for nominal consideration not exceeding $1,000.","Sellers get limited non-exclusive license to use purchased assets for up to 12 months post-closing for winding-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276704,"accession_number":"0001493152-23-026024","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-07-31T23:59:59+00:00","items":["1.01","2.01","5.02","7.01","8.01","9.01"],"status":"ready","headline":"TRxADE closes Superlatus acquisition, regains Nasdaq compliance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired Superlatus; shareholders received 136,441 common shares (19.99% stake) and 306,855 Series B Preferred (100:1 conversion).","Issued MEDS Rights: 7 rights per share held on July 28, 2023; each right allows one free common share upon signing registration rights agreement.","Appointed Candice Beaumont as director; she is Superlatus's Executive Director with 20+ years in finance, banking, M&A.","Regained compliance with Nasdaq's $2.5M minimum stockholders' equity requirement under listing rule 5550(b)(1).","Lock-up agreements: 360-day restriction on sale/transfer of shares for certain Superlatus and MEDS stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276703,"accession_number":"0001493152-23-024613","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-07-14T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"TRxADE Health amends merger with Superlatus; adds share rights for existing holders","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Superlatus shareholders get 30,821,941 shares at $7.30: 136,441 common (19.99% post-merger) and 306,855 Series B convertible preferred (100:1).","TRxADE to issue non-transferable MEDS Rights: 7 rights per share held, each for one free common share, record date one day before closing.","Ancillary document deadline extended to 10 days; certain MEDS equity holders will sign lock-up agreements.","Rights holders must sign Registration Rights Agreement; shares locked for one year post-closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":276702,"accession_number":"0001493152-23-024127","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"TRxADE Health regains Nasdaq minimum bid price compliance; matter closed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq Compliance Letter on July 7, 2023 confirming regained compliance with Bid Price Requirement (Rule 5550(a)(2)).","Closing bid price was at or above $1.00 for 10 consecutive business days from June 22 to July 6, 2023.","Previously disclosed non-compliance in December 2022; now considered closed by Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294505,"accession_number":"0001493152-23-023016","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-06-30T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"TRxADE Health to acquire Superlatus, shifting to food & snack industry; new shares to be issued.","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Superlatus shareholders receive 173,463 MEDS shares (136,436 common, 37,027 Series B preferred convertible at 100:1).","MEDS to divest its existing operating business and assets shortly after the merger closes.","Superlatus must acquire Prestige Farms and Sapientia; valuation must be at least $225M.","Combined company to create global consolidation platform for food and healthy snacks.","Merger expected to close in late Q3 or early Q4 2023; Boards unanimously approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":294504,"accession_number":"0001493152-23-022532","cik":1382574,"company_name":"Scienture Holdings, Inc.","ticker":"SCNX","form_type":"8-K","filed_at":"2023-06-26T23:59:59+00:00","items":["3.01","5.03","9.01"],"status":"ready","headline":"TRxADE Health receives Nasdaq delisting notice for insufficient public shares","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified TRxADE on June 23, 2023, that it had ~310,057 publicly held shares, below the 500,000 minimum.","Company must submit a compliance plan by August 7, 2023; failure may result in delisting from Nasdaq.","Created Series B Preferred Stock, each share converting into 100 common shares upon stockholder approval.","If merger with Superlatus, Inc. does not close by Dec 31, 2023, Company will repurchase all Series B shares at original cost."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":16650509.386189256,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-06-26T23:59:59+00:00|294504"}